GSA CAPITAL PARTNERS LLP - RAPT THERAPEUTICS INC ownership

RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 100 filers reported holding RAPT THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.4%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of RAPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$510
-22.4%
30,716
-12.6%
0.04%
-33.3%
Q2 2023$657
+18.0%
35,140
+15.7%
0.07%
+20.0%
Q1 2023$557
-99.9%
30,362
-19.9%
0.06%
-54.5%
Q3 2022$912,000
+349.3%
37,891
+240.7%
0.12%
+303.3%
Q2 2022$203,000
-51.2%
11,121
-41.2%
0.03%
-46.4%
Q1 2022$416,000
+28.8%
18,915
+115.3%
0.06%
+36.6%
Q4 2021$323,000
-68.9%
8,784
-73.7%
0.04%
-61.3%
Q3 2021$1,038,00033,4230.11%
Other shareholders
RAPT THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Column Group LLC 2,680,621$44,551,92129.58%
GREAT POINT PARTNERS LLC 1,458,070$24,233,1234.41%
Euclidean Capital LLC 1,315,798$21,868,5622.39%
Trustees of Columbia University in the City of New York 73,383$1,219,6252.24%
KINGDON CAPITAL MANAGEMENT, L.L.C. 805,828$13,392,8611.54%
Perceptive Advisors 1,920,658$31,921,3361.06%
Deep Track Capital, LP 1,500,000$24,930,0000.96%
Cheyne Capital Management (UK) LLP 20,000$332,4000.96%
Alphabet Inc. 540,270$8,979,2870.58%
BRAIDWELL LP 1,082,512$17,991,3490.57%
View complete list of RAPT THERAPEUTICS INC shareholders